- Home
- HY vs PRTA Comparison
HY vs PRTA Comparison
Compare HY & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HY
- PRTA
- Stock Information
- Founded
- HY 1991
- PRTA 2012
- Country
- HY United States
- PRTA Ireland
- Employees
- HY N/A
- PRTA N/A
- Industry
- HY Construction/Ag Equipment/Trucks
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- HY Industrials
- PRTA Health Care
- Exchange
- HY Nasdaq
- PRTA Nasdaq
- Market Cap
- HY 735.1M
- PRTA 809.8M
- IPO Year
- HY N/A
- PRTA N/A
- Fundamental
- Price
- HY $38.43
- PRTA $5.72
- Analyst Decision
- HY Strong Buy
- PRTA Buy
- Analyst Count
- HY 1
- PRTA 9
- Target Price
- HY $70.00
- PRTA $27.67
- AVG Volume (30 Days)
- HY 55.5K
- PRTA 2.5M
- Earning Date
- HY 08-05-2025
- PRTA 08-07-2025
- Dividend Yield
- HY 3.72%
- PRTA N/A
- EPS Growth
- HY N/A
- PRTA N/A
- EPS
- HY 5.60
- PRTA N/A
- Revenue
- HY $4,162,100,000.00
- PRTA $137,935,000.00
- Revenue This Year
- HY N/A
- PRTA N/A
- Revenue Next Year
- HY $2.55
- PRTA $119.20
- P/E Ratio
- HY $6.91
- PRTA N/A
- Revenue Growth
- HY N/A
- PRTA 54.55
- 52 Week Low
- HY $34.13
- PRTA $4.32
- 52 Week High
- HY $84.44
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- HY 38.89
- PRTA 44.43
- Support Level
- HY $39.33
- PRTA $4.95
- Resistance Level
- HY $42.89
- PRTA $5.53
- Average True Range (ATR)
- HY 1.16
- PRTA 0.34
- MACD
- HY -0.33
- PRTA 0.24
- Stochastic Oscillator
- HY 8.79
- PRTA 78.29
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).